CIK 0001840229
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
MiNK Therapeutics, Inc.
Sign in to watch- Ticker
- INKT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 212-994-8250
- Business address
- 149 FIFTH AVENUE, SUITE 500, NEW YORK, NY, 10010
- Former names
- AgenTus Therapeutics, Inc., AgenTus Therapeutics, Inc.
- 4 Grant or award Director acquired 10,531 shares (grant or award)
- 4 Grant or award Director acquired 12,244 shares (grant or award)
- 4 Grant or award Director acquired 9,846 shares (grant or award)
- 4 Grant or award Director acquired 12,158 shares (grant or award)
- 4 Grant or award Director acquired 9,590 shares (grant or award)
- 4 Open-market buy 10% owner bought 29,678 shares at $1.52 ($45,016)
- 4 Open-market buy 10% owner bought 183,052 shares at an average $1.54 ($281,478)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 10,157 shares (grant or award)
- 4 Grant or award Director acquired 10,086 shares (grant or award)
- 4 Grant or award Director acquired 8,736 shares (grant or award)
- 4 Grant or award Director acquired 7,955 shares (grant or award)
- 4 Grant or award Director acquired 8,168 shares (grant or award)
- 4/A Insider Changes in Ownership
- 4/A Insider Changes in Ownership
- 4/A Other disposition 10% owner disposed of 5,006,397 shares (other)
Page 5 of 8 · 145 filings